Operative fusion of patients with metabolic syndrome increases risk for perioperative complications

Publication date: Available online 30 December 2019Source: Journal of Clinical NeuroscienceAuthor(s): Katherine E. Pierce, Bhaveen H. Kapadia, Cole Bortz, Avery Brown, Haddy Alas, Sara Naessig, Waleed Ahmad, Dennis Vasquez-Montes, Jordan Manning, Erik Wang, Constance Maglaras, Tina Raman, Themistocles S. Protopsaltis, Aaron J. Buckland, Peter G PassiasAbstractMetabolic syndrome is a clustering of clinical findings defined in the literature including hypertension, high glucose, abdominal obesity, high triglyceride, and low high-density lipoprotein cholesterol levels. The purpose of this study was to assess perioperative outcomes in patients undergoing spine fusion surgery with (MetS) and without (no-MetS) a history of metabolic syndrome. Included: Patients ≥18 yrs old undergoing spine fusion procedures diagnosed with MetS components with BL and 1-year follow-up were isolated in a single-center database. Patients in the two groups were propensity score matched for levels fused. 250 spine fusion patients (58 yrs, 52.2%F, 39.0 kg/m2) with an average CCI of 1.92 were analyzed. 125 patients were classified with MetS (60.2 yrs, 52%F, CCI: 3.2). MetS patients were significantly older (p = 0.012). MetS patients underwent significantly more open (Met-S: 78.4% vs No-MetS: 45.6%, p < 0.001) and posterior approached procedures (Met-S: 60.8% vs No-MetS: 47.2%, p = 0.031). Mean operative time: 272.4 ± 150 min (MetS: 288.1 min vs. no-MetS: 259.7; p = 0.089). Average le...
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research